title: Anti-IgE therapy and severe atopic dermatitis: a pediatric perspective.
authors.affiliation: Department of Medicine, Service of Allergy and Clinical Immunology, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Department of Pediatrics, Service of Allergy and Clinical Immunology, Centre Hospitalier Universitaire Sainte-Justine, Montréal, Quebec, Canada.
authors.forename: Jonathan
authors.initials: J
authors.lastname: Lacombe Barrios
authors.affiliation: Department of Medicine, Service of Allergy and Clinical Immunology, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Department of Pediatrics, Service of Allergy and Clinical Immunology, Centre Hospitalier Universitaire Sainte-Justine, Montréal, Quebec, Canada.
authors.forename: Philippe
authors.initials: P
authors.lastname: Bégin
authors.affiliation: Department of Medicine, Service of Allergy and Clinical Immunology, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Department of Pediatrics, Service of Allergy and Clinical Immunology, Centre Hospitalier Universitaire Sainte-Justine, Montréal, Quebec, Canada.
authors.forename: Louis
authors.initials: L
authors.lastname: Paradis
authors.affiliation: Department of Pediatrics, Service of Dermatology, Centre Hospitalier Universitaire Sainte-Justine, Montréal, Quebec, Canada.
authors.forename: Afshin
authors.initials: A
authors.lastname: Hatami
authors.affiliation: Department of Medicine, Service of Allergy and Clinical Immunology, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada.
authors.forename: Jean
authors.initials: J
authors.lastname: Paradis
authors.affiliation: Department of Pediatrics, Service of Allergy and Clinical Immunology, Centre Hospitalier Universitaire Sainte-Justine, Montréal, Quebec, Canada. Electronic address: a.des.roches@umontreal.ca.
authors.forename: Anne
authors.initials: A
authors.lastname: Des Roches
mesh_terms: D000293:Adolescent; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D002648:Child; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D000069444:Omalizumab; D012720:Severity of Illness Index; D055815:Young Adult
chemical_list: D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized; C026408:anti-IgE antibodies; D000069444:Omalizumab